Form 4: Kenvue Inc. Executive Caroline Tillett Reports Stock Transactions
SEC Form 4
Chief Scientific Officer Caroline Tillett reports the vesting and conversion of restricted stock units into Kenvue Inc. common stock, along with the withholding of shares for tax obligations.
Summary
- Caroline Tillett, Chief Scientific Officer of Kenvue Inc., reported transactions involving Kenvue common stock.
- On February 13, 2025, 3,000 restricted stock units (RSUs) vested and were converted into 3,000 shares of common stock.
- Also on February 13, 2025, 1,012 shares were withheld for payment of taxes at a price of $21.23 per share.
- On February 14, 2025, 7,645 RSUs vested and were converted into 7,645 shares of common stock.
- Additionally on February 14, 2025, 19,121 RSUs vested and were converted into 19,121 shares of common stock.
- On February 14, 2025, 2,619 shares were withheld for payment of taxes at a price of $21.75 per share.
- On February 14, 2025, 6,235 shares were withheld for payment of taxes at a price of $21.75 per share.
- Following these transactions, Ms. Tillett directly owns 41,390.2 shares of Kenvue common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment about the company's performance or prospects.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock. These filings provide transparency into insider activity and can be monitored for signals about a company's prospects.
Comparison to Industry Standards
- Executive compensation packages often include restricted stock units (RSUs) that vest over time, aligning executive interests with long-term shareholder value.
- The vesting schedules, such as the three-year vesting mentioned, are typical in executive compensation agreements.
- Withholding shares for tax obligations upon vesting is a standard practice to cover income tax liabilities associated with the vesting of RSUs.
Stakeholder Impact
- The transactions have a minor dilutive effect on existing shareholders due to the issuance of new shares upon RSU vesting.
- The withholding of shares for taxes reduces the number of shares entering the market, potentially mitigating some of the dilutive effect.
Key Dates
| Date | Description |
|---|---|
| 08/23/2023 | Issuer's separation from Johnson & Johnson |
| 02/13/2024 | First vesting date of an RSU award |
| 02/13/2025 | Vesting and conversion of 3,000 RSUs and withholding of 1,012 shares for taxes |
| 02/14/2025 | Vesting and conversion of 7,645 and 19,121 RSUs and withholding of 2,619 and 6,235 shares for taxes |
| 02/13/2026 | Final vesting date of an RSU award |
| 02/18/2025 | Date of Form 4 signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.